ANTISENSE MODULATION OF ENDOTHELIAL LIPASE EXPRESSION - Patent 1539689

(19)

(11)

EP 1 539 689 A2

(12)

(88)	Date of publication A3:
	21.05.2004

(43)	Date of publication:
	15.06.2005 Bulletin 2005/24

(21)	Application number: 03765691.5

(22)	Date of filing: 18.07.2003

(51)	International Patent Classification (IPC)⁷: C07D 201/00

(86)	International application number:
	PCT/US2003/022410

(87)	International publication number:
	WO 2004/009541 (29.01.2004 Gazette 2004/05)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30)

Priority:

19.07.2002 US 397106 P

(71)	Applicant: Pharmacia Corporation
	St. Louis, MO 63006 (US)

(72)	Inventor:
	BHAT, B., Ganesh St. Louis, MO 63141 (US)

(74)	Representative: Hirsch, Denise et al
	PfizerEuropean Pharma Patent Department23-25, avenue de Docteur Lannelongue 75668 Paris Cedex 14 75668 Paris Cedex 14 (FR)

(54)	ANTISENSE MODULATION OF ENDOTHELIAL LIPASE EXPRESSION